Christoph Boss

ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 6

Top Venues

ChemMedChem

RSC medicinal chemistry

Idorsia Pharmaceuticals Ltd

University of Bern (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Idorsia Pharmaceuticals Ltd Jul 01 2017

Switzerland

Senior Director Medicinal chemistry :: Oncology Chemistry

Actelion Pharmaceuticals Ltd Feb 01 1999 - Jun 30 2017

Switzerland

Senior Director Medicinal Chemistry :: Chemistry

Säurefabrik Schweizerhalle Apr 01 1998 - Jan 31 1999

Switzerland

Lab Head :: Process Development

Education History

University of Bern Jul 01 1993 - Oct 30 1996

Switzerland

PHD :: Department of Chemistry and Biochemistry

University of Bern Jun 01 1991 - May 31 1993

Switzerland

MSC :: Department of Chemistry and Biochemistry

University of Bern Sep 01 1988 - Apr 30 1991

Switzerland

BSC :: Department of chemistry and Biochemistry

Publications

Christine Brotschi, Martin H Bolli, John Gatfield, Catherine Roch, Thierry Sifferlen, Alexander Treiber, Jodi T Williams, Christoph Boss
Pyrazole derivatives as selective orexin-2 receptor antagonists (2-SORA): synthesis, structure-activity-relationship, and sleep-promoting properties in rats. RSC medicinal chemistry 15 (1) (2023)
Christine Brotschi, Martin H Bolli, John Gatfield, Catherine Roch, Thierry Sifferlen, Alexander Treiber, Jodi T Williams, Christoph Boss
Pyrazole derivatives as selective orexin-2 receptor antagonists (2-SORA): synthesis, structure-activity-relationship, and sleep-promoting properties in rats. RSC medicinal chemistry 15 (1) (2023)
Amjad Ali, Marcus Bauser, Sophie M Bertrand, Wesley Blackaby, Christoph Boss, Martin Bossart, Adrian Hall, Hayley Binch, Werngard Czechtizky, Harrie J M Gijsen, Helmut Haning, Ingo V Hartung, Paul Kilburn, Gilbert Lassalle, Ulrich Lücking, Jürgen Mack, Martin Missbach, Leena Otsomaa, Antoni Torrens, Michael Wagner, Magnus Walter, Harald Weinstabl, Luc van Hijfte, Franz von Nussbaum
European Medicinal Chemistry Leaders in Industry (EMCL) - On the Status and Future of Medicinal Chemistry Research in Europe. ChemMedChem (2023)
Christine Brotschi, Martin H Bolli, John Gatfield, Bibia Heidmann, Francois Jenck, Catherine Roch, Thierry Sifferlen, Alexander Treiber, Jodi T Williams, Christoph Boss
From Oxadiazole to Triazole Analogues: Optimization toward a Dual Orexin Receptor Antagonist with Improved in vivo Efficacy in Dogs. ChemMedChem 15 (5) (2020)
Christoph Boss, John Gatfield, Christine Brotschi, Bibia Heidmann, Thierry Sifferlen, Markus von Raumer, Gunther Schmidt, Jodi T Williams, Alexander Treiber, Catherine Roch
The Quest for the Best Dual Orexin Receptor Antagonist (Daridorexant) for the Treatment of Insomnia Disorders. ChemMedChem 15 (23) (2020)
Christine Brotschi, Catherine Roch, John Gatfield, Alexander Treiber, Jodi T Williams, Thierry Sifferlen, Bibia Heidmann, Francois Jenck, Martin H Bolli, Christoph Boss
Oxadiazole Derivatives as Dual Orexin Receptor Antagonists: Synthesis, Structure-Activity Relationships, and Sleep-Promoting Properties in Rats. ChemMedChem 14 (13) (2019)

Christoph Boss.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Christoph Boss